Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sindrle
    Senior Member
    • Aug 2013
    • 266

    #1

    How to present a subset of gene expression values from RNAseq in a publication?

    Hi!
    Im curious, my supervisor want to include 5 genes from the Cuffdiff results in a table for publication.

    He just wants fold changes and standard deviation (and star if significant etc), but first of all I don't know how to calculate SD for FC.. Any suggestions?

    If FC+SD is not the solution, what should I send him?


    Thank you very much.
  • sindrle
    Senior Member
    • Aug 2013
    • 266

    #2
    My suggestion so far is:
    1. Take FPKM values and test values

    Here is an example:

    q1_FPKM q1_conf_lo q1_conf_hi
    1,20921 0,404779 2,01361

    q2_FPKM q2_conf_lo q2_conf_hi
    0,833905 0,24662 1,4278

    Gives

    FC loFC hiFC
    0,689627939 0,609270738 0,709074746

    I present this as: 0,69 +/-0.05*

    *just marks if significant.. (based on FDR)

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      Note that the confidence intervals aren't symemetric, so "0.69, 95% CI [0.61, 0.71]" would seem to make more sense.

      Coming up with reasonable confidence intervals or SDs by hand when dispersion is being squeezed with an empirical Bayes method is going to be non-trivial. I remember you mentioning edgeR and such before, so you might ask on the bioconductor email list if there's a convenient function to do this built-in. The authors are pretty responsive on that list.

      Comment

      • sindrle
        Senior Member
        • Aug 2013
        • 266

        #4
        Thank you, its my concerns as well.. But Im on a time limit and must present something very soon.

        Ill try the mailing list!


        Problem with edgeR is the calculation of FPKM and my problem reproducing fold changes etc from CPM/logCPM.

        With Cuffdiff it is possible, FPKM calculations may be reproduced and it has a lot more easy accessible results in the output files.
        Last edited by sindrle; 01-30-2014, 03:22 AM.

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Ah, yeah, the fold change is also shrunken (I think, I'd have to double check), so again you won't normally get the same answer by hand. As an aside, your supervisor is being a bit unreasonable to request these metrics when you actually require a pretty high level of statistical understanding to know how they were created (and your supervisor lacks that understanding). Best of luck dealing with that!

          Comment

          • sindrle
            Senior Member
            • Aug 2013
            • 266

            #6
            I know :S

            But, that is why Im asking here, to get your expert advise how to best present a subfraction of Cuffdiff results in a publication, without doing lots of stupid **** (like Im doing now) :P

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
              by SEQadmin2




              NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
              Today, 06:46 AM
            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-28-2026, 09:57 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-28-2026, 09:51 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            68 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            48 views
            0 reactions
            Last Post SEQadmin2  
            Working...